Sign In
to Vote &
Create Storyboards.
 
News etectRx, a privately held digital health company, has announced that its ID-Cap System, an ingestion event monitoring technology, has been selected for a new study to observe adherence for the HIV prevention drug TRUVADA for PrEP... Contributed Author: etectRx Topics: Regenerative Medicine
0
0
0


Storyboard
Print
Share this Article

Recommended

  • {TITLE}
    {PUBLISHER} - {PUBLISHED_DATE}
    {VIEWS}
  • Create Storyboard